Skip to content
Business Times – Lifestyle
Author:
InspireMD Inc.
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 12, 2026
InspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR Procedures
June 11, 2026
InspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR Procedures
June 8, 2026
InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference
May 6, 2026
InspireMD Reports First Quarter 2026 Financial Results
May 4, 2026
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
May 1, 2026
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System
May 1, 2026
InspireMD to Announce First Quarter 2026 Financial Results
April 29, 2026
InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference
March 31, 2026
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results
March 27, 2026
1
2
Next Page
→